Predict your next investment

HEALTHCARE | Drug Development
cytosolv.com

See what CB Insights has to offer

Stage

Seed | Dead

Total Raised

$500K

Last Raised

$500K

About CytoSolv

CytoSolv develops a drug to help heal wounds. The company is developing the drug from the brain cells of pigs.

CytoSolv Headquarter Location

Providence, Rhode Island, 02029,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CytoSolv

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CytoSolv is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CytoSolv Patents

CytoSolv has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/10/2015

Skeletal system, Traumatology, Acetylcholinesterase inhibitors, Physiology, Inflammations

Application

Application Date

9/10/2015

Grant Date

Title

Related Topics

Skeletal system, Traumatology, Acetylcholinesterase inhibitors, Physiology, Inflammations

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.